Nalls Sherbakoff Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10
Closed -$80 464
2025
Q1
$80 Buy
+10
New +$101 ﹤0.01% 432
2023
Q4
$324 Sell
15
-5
-25% -$92 ﹤0.01% 433
2023
Q3
$372 Hold
20
﹤0.01% 438
2023
Q2
$463 Sell
20
-5
-20% -$126 ﹤0.01% 456
2023
Q1
$611 Buy
+25
New +$669 ﹤0.01% 476

Other funds holding TDOC

Nalls Sherbakoff Group's TDOC Position: Q2 2025 in Review

Nalls Sherbakoff Group sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 10 shares — an estimated $80 sold.

Nalls Sherbakoff Group first reported a position in TDOC in Q1 2023 and held it in 5 quarters. The position peaked at $611 in Q1 2023. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Nalls Sherbakoff Group reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Nalls Sherbakoff Group sold 10 Teladoc Health shares in Q2 2025, an estimated $80.
  • Nalls Sherbakoff Group first reported a position in Teladoc Health in Q1 2023 and held it in 5 quarters.
  • Nalls Sherbakoff Group's Teladoc Health position peaked at $611 in Q1 2023.
  • 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2025, filed 12 Mar 2026.